## MCHP: Microchip Technology Incorporat - XLK: Technology

### Executive Summary

PARABOLIC warning: MRS_10 at 11.3% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops. Caution: momentum weakening (-5.7% MRS).

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($62.03)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Microchip Technology (NASDAQ: MCHP) to webcast talk at Barclays Global Tech Conference**
- Source: Stock Titan | 20251208T210932 | Neutral | Relevance: 99%
- Microchip Technology (NASDAQ: MCHP) announced it will present at the Barclays 23rd Annual Global Technology Conference on Thursday, December 11, 2025, at 1:20 p.m. PT. COOs Rich Simoncic and Senior VP and CFO Eric Bjornholt will represent the company, with a live webcast available on Microchip's website. This presentation continues Microchip's proactive investor outreach, following recent positive news including raised financial guidance and new product launches that led to stock gains.

**2. Microchip Technology Incorporated to Present at Barclays 23rd Annual Global Technology Conference**
- Source: Quiver Quantitative | 20251208T212340 | Somewhat-Bullish | Relevance: 99%
- Microchip Technology Inc. (MCHP) announced its participation in the Barclays 23rd Annual Global Technology Conference on December 11, 2025, at 1:20 p.m. Pacific Time. COO Rich Simoncic and Senior VP and CFO Eric Bjornholt will represent the company, with a live webcast available on Microchip's website. The article also provides recent insider trading activity, revenue data, hedge fund holdings, analyst ratings, and price targets for MCHP.

**3. Amundi Sells 6,986,394 Shares of Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251207T081845 | Neutral | Relevance: 99%
-  Amundi significantly reduced its stake in Microchip Technology Incorporated (MCHP) by selling 6,986,394 shares, decreasing its holdings by 69.8% to 3,026,891 shares valued at $221.4 million. Despite this, other institutional investors have shown varied activity, with some increasing their positions. The article also provides a financial overview of Microchip Technology, including recent earnings, dividend announcements, and analyst ratings.

**4. California Public Employees Retirement System Sells 457,172 Shares of Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251208T095806 | Neutral | Relevance: 98%
-  California Public Employees Retirement System (CalPERS) has reduced its stake in Microchip Technology Inc. (MCHP) by 14.9%, selling 457,172 shares in Q2 and now holding 2,606,181 shares valued at approximately $183.4 million. Despite this, other major institutions like Vanguard, Invesco, and Boston Partners significantly increased their positions, resulting in hedge funds and institutions owning about 91.51% of the company's stock. Microchip Technology recently reported Q3 earnings that slightly beat expectations and declared a quarterly dividend of $0.455.

**5. Marshall Wace LLP Sells 445,593 Shares of Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251208T113732 | Somewhat-Bullish | Relevance: 98%
-  Marshall Wace LLP significantly reduced its stake in Microchip Technology Inc. by selling 445,593 shares, decreasing its position by 46.6% in the second quarter. Despite this, other institutional investors have slightly increased their holdings. The semiconductor company recently reported strong earnings, beating analyst estimates, and announced a quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | B of A Securiti | $72 | $67 | +7% |
| 2025-12-04 | Needham | $75 | $73 | +3% |
| 2025-12-03 | Rosenblatt | $80 | $80 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | B of A Securiti | main | Neutral |
| 2025-12-04 | Needham | main | Buy |
| 2025-12-03 | Rosenblatt | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 13 ($0.23M) |
| Sells | 8 ($0.25M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (+2.1%)
- Blackrock Inc.: 9.7% (-2.0%)
- Tudor Investment Cor: 9.5% (+100.0%)
- State Street Corpora: 5.2% (-11.9%)
- Boston Partners: 3.0% (+9.5%)

### Key Risks

1. Valuation stretched: PEG 5.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.70 signals overvaluation risk, limited margin of safety. Forward P/E 26.8x attractive for 72% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment positive (2 raises, avg +5%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.1B |
| Beta | 1.46 |
| 52W Range | $34.13 - $77.20 |
| Short Interest | 5.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.70 |
| Forward P/E | 26.8 |
| Current P/E | 46.0 |
| YoY Growth | 71.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 17.0% to 11.3% (-5.7% in 5 days), indicating relative weakness vs NASDAQ. Extended beyond STRENGTH zone (11.3% > 6.0%), caution on chasing. MRS_5 at 1.6% confirms short-term momentum alignment. Outperforming sector by 10.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.13), confirming momentum. RSI overbought at 71, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 11.29% (CS: 98) | Strong |
| RSI_14 | 70.7 | Overbought |
| MACD Histogram | 2.13 | Bullish |
| vs SMA20 | 1.194x | Above |
| vs SMA50 | 1.104x | Above |
| vs SMA200 | 1.107x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $66.85
- **Stop Loss:** $62.03 (7.2% risk)
- **Target:** $71.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 248
- **Position Value:** $16,578.80
- **Portfolio %:** 16.58%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-05 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +4.9% |
| 2025Q2 | $0.24 | $0.27 | +13.2% |
| 2025Q1 | $0.10 | $0.11 | +5.3% |
| 2024Q4 | $0.28 | $0.20 | -28.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*